Pomalidomide Active Not Recruiting Phase 1 Trials for Light Chain Deposition Disease / Primary Systemic Amyloidosis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01728259First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD